Journal Supplement |
Journal Supplement
Mark S. Sulkowski, MD, and a team of expert faculty contributors discuss the management of HBV, HCV, and cirrhosis in HIV-infected patients in this supplement to the Journal of Acquired Immune Deficiency Syndromes (Volume 45, Supplement 2, July 1, 2007). Order your free copy of this important and informative journal supplement today! |
Tx Reporter |
Tx Reporter
Uncomplicated skin and skin structure infections (uSSSIs) are among the most frequently seen—and challenging—infections in the community setting. In this detailed review of pediatric uSSSIs, Ronald N. Jones, MD, and Dennis L. Stevens, MD, examine the latest treatment advances, including the use of topical treatment; outline the differences between community-acquired and hospital-acquired methicillin-resistant S. aureus; and offer guidance on determining when to hospitalize a child with a skin infection. This downloadable Tx Reporter is targeted to pediatricians, dermatologists, and infectious disease specialists. |
On-Demand Webcast |
On-Demand Webcast
Skin and skin structure infections account for up to 18% of visits to pediatricians, but their empiric treatment is no longer routine. While Staphylococcus aureus and Streptococcus pyogenes remain the most frequently isolated gram-positive pathogens in uncomplicated skin infections, the increasing prevalence of methicillin-resistant S aureus makes culture and follow-up imperative. Where resistance rates are particularly high, cephalosporins, the most prescribed office antibiotics, will not be effective. Fortunately, some new therapies have been developed that offer promise.
For this reason, experts in dermatology, pediatrics, and microbiology recently convened in Atlanta for 7 mini-symposia, to examine the changing epidemiology of these infections, how to recognize their varying presentation, the selection of topical versus oral therapy, and when to consider hospitalization. |
Podcasts |
Podcasts
Newsmakers In Medicine—Infectious Diseases Edition presents a 4-part CME audio podcast program that provides practical answers to commonly asked clinicians' questions on pediatric skin and skin structure infections.
This 4-part series on uncomplicated skin and skin structure infections features discussions on:
- Growing prevalence of methicillin-resistant Staphylococcus aureus infection in the community
- Current practices in culturing and empiric prescribing
- Factors contributing to resistance
- When topical treatment may be appropriate
The podcasts are available as streaming audio or can be downloaded to a computer or MP3 player. Earn CME credit by taking the posttest for each podcast.
|
Tx Reporter Series |
Tx Reporter Series
We are pleased to bring you this important and timely series with the latest information and practical applications. We hope you find it helpful in improving outcomes in your patients with invasive fungal infections. |
Audio Interviews |
Audio Interviews
Newsmakers In Medicine™ is designed for primary care physicians and other clinicians who need rapid and convenient access to state-of-the-science data and practical insights on important clinical topics. This 9-part series of 15-minute audio interviews conducted with experts on infectious diseases explores the growing prevalence of hepatitis A and hepatitis B virus infections and provides cutting-edge information about prevention through vaccination. |
CME Newsletter |
This activity has reached its termination date and no longer offers continuing education credit.
Order Your Tx Reporter Today!
The discussions contained within The Pharmacology of Antiretroviral Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs): Implications for Once-Daily Dosing will help you to understand the plasma and intracellular pharmacokinetic properties of NRTIs and how these properties determine a drug's appropriateness for once-daily dosing and placement within a once-daily regimen. This understanding will serve as the foundation on which you can construct simplified and effective therapies for individual patients.
|
CME Newsletter |
This activity has reached its termination date and no longer offers continuing education credit.
Click here to Order the Tx Reporter
In this newsletter, the faculty have selected key samples from the clinical trials presented at this meeting in order to show you the nature of current research, including interim and final findings from major studies and recent preliminary data from smaller studies, as well as to suggest areas for further study. Our goal was to focus on trials representing issues that affect clinicians in their daily practice: improving response in special populations, including African Americans and HIV/HCV coinfected patients; giving prior nonresponders an opportunity for virologic response and/or histologic response through retreatment or maintenance therapy; prescribing the appropriate duration of therapy based on genotype and early virologic response; understanding the differences between the available peginterferon products; and managing acute HCV infection. |
 |
This activity has reached its termination date and no longer offers continuing education credit.
Order Free Interactive CD-ROM Game
Test Your Clinical Management Skills! Play the game, and see how your score compares with the "experts’ recommendations" for 16 coinfection cases.
Earn game points while you:
* Select appropriate treatment candidates
* Individualize dosing
* Determine response and duration of therapy
* Monitor for and manage hepatotoxicity and drug interactions
|
 |
This activity has reached its termination date and no longer offers continuing education credit.
View/Download Newsletter
Clinicians managing HCV-infected patients face a dilemma: how to maintain patients on the full dose of antiviral therapy for the recommended duration of time while avoiding treatment-induced anemia and its negative impact on quality of life, or possible dose reduction and discontinuation of treatment. In this newsletter, leading experts offer models of care from other disease states that physicians may successfully apply to benefit their
patients on anti-HCV therapy. |
|
This activity has reached its termination date and no longer offers continuing education credit.
Order/Download Monographs I, II, III
These monographs provides an opportunity for clinicians who work with HIV-infected patients to learn more about HCV, which is an increasingly relevant opportunistic infection. They provide the most current information about recent treatment advances. |
|
This activity has reached its termination date and no longer offers continuing education credit.
Order Syllabus, CD-Rom
Order a syllabus or interactive continuing medical education CD-ROM from a satellite symposium which preceded the Infectious Disease Society of America (IDSA) annual meeting that examines HIV/HCV coinfection in the era of highly active antiretroviral therapy (HAART.) |
|
This activity has reached its termination date and no longer offers continuing education credit.
View Web Cast Replay
View/Order Monograph, Newsletter, or
Slide Kit on CD
Enjoy a web cast replay of this innovative CME activity, which highlights data on pegylated formulations of interferon, either in combination with ribavirin or as monotherapy. Order enduring materials online. Real Player G2 format. |
